OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy
Pablo García‐Pavía, José F. Rodríguez‐Palomares, Gianfranco Sinagra, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 10
Pablo García‐Pavía, José F. Rodríguez‐Palomares, Gianfranco Sinagra, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 10
Showing 10 citing articles:
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine
Marta Gigli, Davide Stolfo, Marco Merlo, et al.
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 5
Marta Gigli, Davide Stolfo, Marco Merlo, et al.
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 5
LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy
Ze Wang, Jiahao Wu, Zhongwei Lv, et al.
Journal of Advanced Research (2025)
Open Access
Ze Wang, Jiahao Wu, Zhongwei Lv, et al.
Journal of Advanced Research (2025)
Open Access
Contemporary Insights into LMNA Cardiomyopathy
Iswaree Devi Balakrishnan, Neal K. Lakdawala
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Iswaree Devi Balakrishnan, Neal K. Lakdawala
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Genetik der Kardiomyopathien und Arrhythmien – Risikobeurteilung und Therapieperspektive
Michael J. Wisdom, Benjamin Meder
Deleted Journal (2025)
Closed Access
Michael J. Wisdom, Benjamin Meder
Deleted Journal (2025)
Closed Access
Advances in the study and treatment of genetic cardiomyopathies
Victoria N. Parikh, Sharlene M. Day, Neal K. Lakdawala, et al.
Cell (2025) Vol. 188, Iss. 4, pp. 901-918
Closed Access
Victoria N. Parikh, Sharlene M. Day, Neal K. Lakdawala, et al.
Cell (2025) Vol. 188, Iss. 4, pp. 901-918
Closed Access
Phenotypic diversity of the LMNA mutations
Ali J. Marian
Current Opinion in Cardiology (2025) Vol. 40, Iss. 3, pp. 126-130
Closed Access
Ali J. Marian
Current Opinion in Cardiology (2025) Vol. 40, Iss. 3, pp. 126-130
Closed Access
Characterization and natural history of patients with LMNA‐related dilated cardiomyopathy in the phase 3 REALM‐DCM trial
Pablo García‐Pavía, Neal K. Lakdawala, Gianfranco Sinagra, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 4201-4208
Open Access | Times Cited: 2
Pablo García‐Pavía, Neal K. Lakdawala, Gianfranco Sinagra, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 4201-4208
Open Access | Times Cited: 2
Innovation of Lipid‐Based Nanoparticles: the Design and Applications in the Cardiovascular Disease Management
Zhengying Gu, Tianbao Liu, Wutian Rao, et al.
Advanced Functional Materials (2024) Vol. 35, Iss. 2
Open Access | Times Cited: 1
Zhengying Gu, Tianbao Liu, Wutian Rao, et al.
Advanced Functional Materials (2024) Vol. 35, Iss. 2
Open Access | Times Cited: 1
Toward Precision Medicine in the Treatment of Arrhythmogenic Cardiomyopathy
Michael B. Liu, Victoria N. Parikh
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 26, Iss. 11, pp. 317-330
Closed Access
Michael B. Liu, Victoria N. Parikh
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 26, Iss. 11, pp. 317-330
Closed Access
“The unbearable lightness” of the primary end point in clinical trials
Ali J. Marian
Molecular and Cellular Biochemistry (2024)
Closed Access
Ali J. Marian
Molecular and Cellular Biochemistry (2024)
Closed Access
